Levomefolic Acid>98.0%(HPLC)50mg

TERT-BUTYL 2,6-DIAZASPIRO[3.4]OCTANE-6-CARBOXYLATE HCL, 95.0%, 5g

(R)-Methyl 2-amino-3-(naphthalen-1-yl)propanoate hydrochloride, 95%, 500mg

(4-Methylpiperidin-1-yl)(piperidin-4-yl)methanone hydrochloride, 95.0%, 500mg

Benzyl (2,2-dimethoxyethyl)(methyl)carbamate, 95%, 10g

ETHYL 6-METHOXYBENZOFURAN-2-CARBOXYLATE, 97.0%, 1g

ETHYL 6-NITRONICOTINATE, 95.0%, 250mg

((R)-3-([1,1'-Biphenyl]-4-yl)-2-(N,3,5-trimethylbenzamido)propanoyl)-L-tryptophan, 97%, 1mg

Methyl 6-bromopyrazine-2-carboxylate, 95.0%, 5g

Acide de tungstène, min 99 %, pa, 25 g, emballage plastique.

(2E)-3-pyrazin-2-ylacrylic acid, 95%, 1g

Tolbutamide, 95.0%, 1g

H-Ile-CMK�HCl, 95.0%, 1g